Glaxosmithkline | Zysk Brutto Na Sprzedaży



Gross Profit On Sales Zmiana Data
AbbVie USD 10.71B 458M 2024-12
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Aurora Cannabis CAD 9.35M 6.18M 2024-12
Bausch Health Companies USD 1.56B 274M 2025-03
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 178.93M 745K 2024-12
Drreddys Laboratories INR 49.05B 1.28B 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
GlaxoSmithKline GBP 5.59B 34M 2025-03
Glaxosmithkline GBP 5.6B 94M 2024-12
Indivior 222M 54M 2025-03
J&J USD 14.6B 816M 2025-03
Merck USD 12.77B 849M 2025-03
Novartis USD 10.23B 294M 2024-12
Pacira USD 147.37M 17.66M 2024-12
Perrigo USD 385.9M 18.5M 2024-12
Pfizer USD 11.12B 987M 2025-03
Prestige Brands USD 161.05M 3.67M 2024-12
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.72B 2.36B 2025-03
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
Takeda JPY 727.25B 54.48B 2024-12
Teva Pharmaceutical Industries USD 2.12B 85M 2024-12
Zoetis USD 1.61B 79M 2024-12



Glaxosmithkline Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.